Interventional cardiology in a whole new light

Open menu

News & Events

ATTEND THE OPSENS MEDICAL SPONSORED SYMPOSIUM AT THE CRT 2018 CONFERENCE

19 February 2018

Attend the Opsens sponsored complimentary lunch educational symposium, “Upgrading Coronary Physiologic Approaches: Methods, Myths, and Best Practices” at CRT (Cardiovascular Research Technologies) 2018 Conference in Washington, DC. Opsens offers the first fiber-optic FFR guidewire with nitinol core, providing superior handling, functionality and accuracy, particularly beneficial in complex PCI. Leading experts in coronary physiology will demonstrate clinical utility…

Read more

OPSENS’ JAPANESE PARTNER ZEON MEDICAL PROCEEDS WITH CONVERSION OF US$2 MILLION DEBENTURE

27 November 2017

Quebec City, Quebec, November 27, 2017 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) is pleased to announce the conversion of the US$2 million debenture held by Zeon Medical Inc. (“Zeon Medical”), Opsens’ Japanese partner. Zeon Medical has been a client of Opsens since 2004. In 2012, Opsens granted Zeon Medical the exclusive distribution rights for…

Read more

OPSENS REPORTS 2017 RESULTS – CONSOLIDATED REVENUES UP 85% FOR FISCAL 2017

15 November 2017

  OPSENS REPORTS 2017 RESULTS – CONSOLIDATED REVENUES UP 85% FOR FISCAL 2017 Quebec City, Quebec, November 15, 2017 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) today reported its results for the year ended August 31, 2017. Highlights Record consolidated revenues for fiscal year 2017 at $17.8 million; Revenues for Fractional Flow Reserve (“FFR”)…

Read more

OPSENS GETS TECHNOLOGICAL AWARD

24 October 2017

Quebec City, Quebec, October 24, 2017 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) is proud to announce that its wholly owned subsidiary Opsens Solutions has received the first prize in the category “Best Innovative Product – Physics Measurements” in the Technological Awards Ranking of the magazine Mesures. This honor was bestowed upon Opsens during…

Read more

VISIT OPSENS MEDICAL AT TCT 2017

25 September 2017

Learn more about OptoWire at booth #5014 at the Transcatheter Cardiovascular Therapeutics Conference (TCT) 2017, and attend the Opsens sponsored complimentary lunch educational symposium, “Beyond FFR: New Nonhyperemic Indices in the Cath Lab”. Educational Symposium Objectives:  Update on procedures involving challenging patient subsets Examine current evidence related to FFR and non-hyperemic indices Case review of FFR and non-hyperemic index…

Read more

OPSENS PRESENTS A SHORT FILM AT THE INTERNATIONAL MEDICAL FILM FESTIVAL

19 September 2017

OPSENS PRESENTS A SHORT FILM AT THE INTERNATIONAL MEDICAL FILM FESTIVAL Quebec City, Quebec, September 13, 2017 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) is proud to announce that it has been invited to present a short film as part of International Medical Film Festival – Quebec in Good Health. The film features the OptoWire, Opsens’…

Read more

Opsens – Q3 Results

29 June 2017

OPSENS REPORTS Q3 2017 RESULTS  ANOTHER RECORD QUARTER WITH REVENUES UP 130% TO $4.9 MILLION Quebec City, Quebec, June 29, 2017 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) today reported its results for the third quarter ended May 31, 2017. Highlights Growth in sales of products to measure Fractional Flow Reserve (“FFR”) in Q3 2017 to…

Read more

VISIT OPSENS MEDICAL AT THE 13TH ANNUAL C3 CONFERENCE

9 June 2017

Learn more about OptoWire Deux at booth #211 at the 13th Annual Complex Cardiovascular Catheter Therapeutics (C3) Conference, and attend the Opsens sponsored complimentary breakfast educational symposium, “Applying Advanced Physiology Technology in the New PCI Era”. This program is geared toward the interventionalist seeking to better understand complex PCI in the modern era. Presentations will…

Read more

ROBIN VILLENEUVE APPOINTED AS CHIEF FINANCIAL OFFICER

7 June 2017

ROBIN VILLENEUVE APPOINTED AS CHIEF FINANCIAL OFFICER Quebec City, Quebec, June 7, 2017 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS)(OTCQX:OPSSF) today announces that to support its growth phase and positioning in the medical market, the Company recruited Robin Villeneuve as Chief Financial Officer. This appointment enters into force immediately. Mr. Villeneuve recently worked as…

Read more

OPSENS ANNOUNCES DEPARTURE OF CFO

5 May 2017

OPSENS ANNOUNCES DEPARTURE OF CFO Quebec City, Quebec, May 05, 2017 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) has today announced the departure of Mr. Thierry Dumas, Chief Financial Officer and Corporate Secretary. Mr. Dumas will leave the Company on May 12, 2017. Mr. Louis Laflamme, Opsens’ current President and Chief Executive Officer, will assume…

Read more